查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1607129

功能基因組學市場：按產品/服務、技術、應用和最終用戶 - 2025-2030 年全球預測

Functional Genomics Market by Product & Service (Consumables, Services, Systems & Software), Technology (Microarray, Next-Generation Sequencing, Nucleic Acid Extraction & Purification), Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年功能基因組市值為161.9億美元，預計到2024年將達到183億美元，複合年成長率為13.96%，到2030年將達到404.2億美元。

功能基因組學是基因組學的一個分支，專注於了解生物系統中基因的功能和相互作用。利用基因表現和基因組編輯技術等方法，我們探索基因突變如何影響細胞功能以及它們如何參與疾病。對功能基因組學的需求源於其在個人化醫療、藥物發現和疾病診斷進展中的關鍵作用。其應用涵蓋生物技術、製藥和農業等多個領域，有助於開發標靶治療以及開發提高產量和抗性的基因改造作物。該市場的最終用途包括學術研究機構、臨床實驗室和生物技術公司，希望利用先進的基因組見解來提供創新解決方案。

主要市場統計
基準年[2023] 161.9億美元
預測年份 [2024] 183億美元
預測年份 [2030] 404.2億美元
複合年成長率（%） 13.96%

市場成長是由次世代定序和 CRISPR-Cas9 等技術進步以及需要新治療方法的慢性病日益普及所推動的。此外，政府和私人對基因組研究的資助促進了創新，學術界和工業界之間的合作促進了轉化研究。最近，透過整合人工智慧和機器學習來分析複雜的基因組資料集，增強預測模型並加速藥物發現過程的機會出現了。為了抓住這些機會，公司應該投資先進的資料分析平台並促進跨學科研究合作。

然而，這個市場面臨著挑戰​​，包括高昂的設備成本、複雜的資料管理要求以及圍繞遺傳資料的使用和操縱的道德問題。此外，監管障礙和資料隱私問題可能會阻礙功能基因組學技術的無縫採用。精確基因編輯、合成生物學和簡化資料分析的生物資訊學工具等領域的創新可能會蓬勃發展。探索開發方便用戶使用的基因組資料解釋平台有可能擴大不同領域的存取和效用。隨著研究技術和分析能力的不斷突破，市場動態是動態且快速發展的，需要不斷適應和策略遠見來保持競爭優勢。

市場動態：揭示快速發展的功能基因組市場的關鍵市場洞察

供需的動態交互作用正在改變功能基因體學市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 擴大使用功能基因組學進行癌症研究和治療
    • 政府資助功能基因組計劃的研究和開發
    • 基因組技術的重大進展
  • 市場限制因素
    • 功能基因體學研究需要昂貴的設備、試劑和資源
  • 市場機會
    • 全球客戶對個人化藥物的偏好日益成長
    • 功能基因組解決方案的有利核准場景
  • 市場挑戰
    • 道德和監管問題

波特的五力：駕馭功能基因體學市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解功能基因組市場的外部影響

外部宏觀環境因素在塑造功能基因組學市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析功能了解基因組市場的競爭狀況

功能基因組學市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣功能基因組市場供應商績效評估

FPNV 定位矩陣是評估功能基因體學市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了功能基因組學市場的成功之路

功能基因組學市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5.產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 在癌症研究和治療中擴大使用功能基因組學
      • 政府支持功能基因組計劃研發資金
      • 基因組技術的重大進展
    • 抑制因素
      • 功能基因體學研究需要昂貴的設備、試劑和資源
    • 機會
      • 全球客戶對個人化藥物的偏好增加
      • 功能基因組解決方案的有利核准場景
    • 任務
      • 有關道德和監管問題
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章功能基因組市場：依產品/服務分類

  • 消耗品
  • 服務
  • 系統及軟體

第7章功能基因體市場：依技術分類

  • 微陣列
  • 次世代定序
  • 核酸萃取精製
  • 聚合酵素鏈鎖反應(PCR)

第8章功能基因體學市場：依應用分類

  • 診斷
  • 藥物發現與開發

第9章功能基因組學市場：依最終用戶分類

  • 醫院/診所
  • 製藥和生物技術公司
  • 研究中心及學術

第10章美洲功能基因組市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區功能基因體市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲的功能基因組市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • 10x Genomics, Inc.
  • Agilent Technologies, Inc.
  • AstraZeneca plc
  • Bio-Rad Laboratories, Inc.
  • Biomatters Limited
  • Bionano Genomics, Inc.
  • C2i Genomics
  • Congenica Ltd.
  • Danaher Corporation
  • Eagle Genomics
  • Eppendorf SE
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche AG
  • Fabric Genomics, Inc.
  • Merck & Co., Inc.
  • Myriad Genetics, Inc.
  • Nest Health Tech Inc.
  • Novogene Co., Ltd.
  • Oxford Nanopore Technologies PLC
  • Pacific Biosciences of California, Inc.
  • Personalis, Inc.
  • QIAGEN NV
  • Quest Diagnostics Incorporated
  • Rapid Genomics by LGC Biosearch Technologies
  • Thermo Fisher Scientific Inc.
  • Vizgen, Inc.
Product Code: MRR-2E76C3E47FBB

The Functional Genomics Market was valued at USD 16.19 billion in 2023, expected to reach USD 18.30 billion in 2024, and is projected to grow at a CAGR of 13.96%, to USD 40.42 billion by 2030.

Functional genomics is a branch of genomics focused on understanding gene functions and interactions within a biological system. It explores how genetic mutations impact cellular functions and contribute to diseases, utilizing approaches such as gene expression profiling and genome editing technologies. The necessity of functional genomics emerges from its pivotal role in advancing personalized medicine, drug discovery, and disease diagnostics. Its application spans various sectors, including biotechnology, pharmaceuticals, and agricultural industries, enabling the development of targeted therapies and genetically engineered crops for improved yield and resistance. The market's end-use scope includes academic research institutions, clinical laboratories, and biotech companies, aiming to leverage advanced genomic insights for innovative solutions.

KEY MARKET STATISTICS
Base Year [2023] USD 16.19 billion
Estimated Year [2024] USD 18.30 billion
Forecast Year [2030] USD 40.42 billion
CAGR (%) 13.96%

Market growth is propelled by technological advancements, such as next-generation sequencing and CRISPR-Cas9, and the increasing prevalence of chronic diseases that necessitate novel therapeutic approaches. Additionally, government and private funding for genomic research fosters innovation, while collaborations between academia and industry expedite translational research. Recent opportunities arise in the integration of artificial intelligence and machine learning to analyze complex genomic data sets, thereby enhancing predictive modeling and accelerating drug discovery processes. To seize these opportunities, companies should invest in advanced data analytics platforms and foster cross-disciplinary collaborations.

However, the market faces challenges including high instrumentation costs, complex data management requirements, and ethical concerns surrounding genetic data usage and manipulation. Moreover, regulatory hurdles and data privacy issues could impede the seamless adoption of functional genomics technologies. Innovation can flourish in areas such as precision gene editing, synthetic biology, and bioinformatics tools that streamline data analysis. Exploring the development of user-friendly platforms for genomic data interpretation could broaden access and utility across diverse sectors. The nature of the functional genomics market is dynamic, rapidly evolving with continual breakthroughs in research techniques and analytics capabilities, which necessitates ongoing adaptation and strategic foresight to maintain competitive advantage.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Functional Genomics Market

The Functional Genomics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing use of functional genomics for cancer research and treatment
    • Supportive government funding for R&D in functional genome projects
    • Significant advancements in genomic technologies
  • Market Restraints
    • Need of expensive equipment, reagents and resources for functional genomics research
  • Market Opportunities
    • Growing customer preference for personalized medicines worldwide
    • Favorable approval scenario for functional genomic solutions
  • Market Challenges
    • Issues pertaining to ethical and regulatory challenges

Porter's Five Forces: A Strategic Tool for Navigating the Functional Genomics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Functional Genomics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Functional Genomics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Functional Genomics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Functional Genomics Market

A detailed market share analysis in the Functional Genomics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Functional Genomics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Functional Genomics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Functional Genomics Market

A strategic analysis of the Functional Genomics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Functional Genomics Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., Agilent Technologies, Inc., AstraZeneca plc, Bio-Rad Laboratories, Inc., Biomatters Limited, Bionano Genomics, Inc., C2i Genomics, Congenica Ltd., Danaher Corporation, Eagle Genomics, Eppendorf SE, Eurofins Scientific SE, F. Hoffmann-La Roche AG, Fabric Genomics, Inc., Merck & Co., Inc., Myriad Genetics, Inc., Nest Health Tech Inc., Novogene Co., Ltd., Oxford Nanopore Technologies PLC, Pacific Biosciences of California, Inc., Personalis, Inc., QIAGEN N.V., Quest Diagnostics Incorporated, Rapid Genomics by LGC Biosearch Technologies, Thermo Fisher Scientific Inc., and Vizgen, Inc..

Market Segmentation & Coverage

This research report categorizes the Functional Genomics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product & Service, market is studied across Consumables, Services, and Systems & Software.
  • Based on Technology, market is studied across Microarray, Next-Generation Sequencing, Nucleic Acid Extraction & Purification, and Polymerase Chain Reaction (PCR).
  • Based on Application, market is studied across Diagnostics and Drug Discovery & Development.
  • Based on End-User, market is studied across Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, and Research Centers & Academic.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing use of functional genomics for cancer research and treatment
      • 5.1.1.2. Supportive government funding for R&D in functional genome projects
      • 5.1.1.3. Significant advancements in genomic technologies
    • 5.1.2. Restraints
      • 5.1.2.1. Need of expensive equipment, reagents and resources for functional genomics research
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing customer preference for personalized medicines worldwide
      • 5.1.3.2. Favorable approval scenario for functional genomic solutions
    • 5.1.4. Challenges
      • 5.1.4.1. Issues pertaining to ethical and regulatory challenges
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Functional Genomics Market, by Product & Service

  • 6.1. Introduction
  • 6.2. Consumables
  • 6.3. Services
  • 6.4. Systems & Software

7. Functional Genomics Market, by Technology

  • 7.1. Introduction
  • 7.2. Microarray
  • 7.3. Next-Generation Sequencing
  • 7.4. Nucleic Acid Extraction & Purification
  • 7.5. Polymerase Chain Reaction (PCR)

8. Functional Genomics Market, by Application

  • 8.1. Introduction
  • 8.2. Diagnostics
  • 8.3. Drug Discovery & Development

9. Functional Genomics Market, by End-User

  • 9.1. Introduction
  • 9.2. Hospitals & Clinics
  • 9.3. Pharmaceutical & Biotechnology Companies
  • 9.4. Research Centers & Academic

10. Americas Functional Genomics Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Functional Genomics Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Functional Genomics Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 10x Genomics, Inc.
  • 2. Agilent Technologies, Inc.
  • 3. AstraZeneca plc
  • 4. Bio-Rad Laboratories, Inc.
  • 5. Biomatters Limited
  • 6. Bionano Genomics, Inc.
  • 7. C2i Genomics
  • 8. Congenica Ltd.
  • 9. Danaher Corporation
  • 10. Eagle Genomics
  • 11. Eppendorf SE
  • 12. Eurofins Scientific SE
  • 13. F. Hoffmann-La Roche AG
  • 14. Fabric Genomics, Inc.
  • 15. Merck & Co., Inc.
  • 16. Myriad Genetics, Inc.
  • 17. Nest Health Tech Inc.
  • 18. Novogene Co., Ltd.
  • 19. Oxford Nanopore Technologies PLC
  • 20. Pacific Biosciences of California, Inc.
  • 21. Personalis, Inc.
  • 22. QIAGEN N.V.
  • 23. Quest Diagnostics Incorporated
  • 24. Rapid Genomics by LGC Biosearch Technologies
  • 25. Thermo Fisher Scientific Inc.
  • 26. Vizgen, Inc.

LIST OF FIGURES

  • FIGURE 1. FUNCTIONAL GENOMICS MARKET RESEARCH PROCESS
  • FIGURE 2. FUNCTIONAL GENOMICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS FUNCTIONAL GENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS FUNCTIONAL GENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES FUNCTIONAL GENOMICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES FUNCTIONAL GENOMICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC FUNCTIONAL GENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC FUNCTIONAL GENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA FUNCTIONAL GENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA FUNCTIONAL GENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. FUNCTIONAL GENOMICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. FUNCTIONAL GENOMICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. FUNCTIONAL GENOMICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. FUNCTIONAL GENOMICS MARKET DYNAMICS
  • TABLE 7. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, BY SYSTEMS & SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, BY NUCLEIC ACID EXTRACTION & PURIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, BY RESEARCH CENTERS & ACADEMIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS FUNCTIONAL GENOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES FUNCTIONAL GENOMICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC FUNCTIONAL GENOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA FUNCTIONAL GENOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM FUNCTIONAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM FUNCTIONAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM FUNCTIONAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM FUNCTIONAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. FUNCTIONAL GENOMICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 192. FUNCTIONAL GENOMICS MARKET, FPNV POSITIONING MATRIX, 2023